Education
About Us
Working with TipRanks
Follow Us
Rocket Pharmaceuticals (RCKT)
NASDAQ:RCKT
RCKT Analyst Ratings
Moderate Buy
6 Buy
3 Hold
1 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
RCKT Stock 12 Month Forecast
Average Price Target
$9.14
▲(164.93% Upside)
| Highest Price Target$16.00 | Average Price Target$9.14 | Lowest Price Target$5.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Evercore ISI
$5
Hold
44.93%
Upside
Reiterated
12/17/25
J.P. Morgan
Sell
―
Downgraded
11/18/25
Bank of America Securities
$10→$8
Buy
131.88%
Upside
Reiterated
11/18/25
LifeSci Capital
$9
Buy
160.87%
Upside
Reiterated
11/07/25
Needham
Hold
―
Reiterated
11/07/25
Wedbush
$16
Buy
363.77%
Upside
Reiterated
11/07/25
Cantor Fitzgerald
$8
Buy
131.88%
Upside
Reiterated
11/06/25
Chardan Capital
$12→$11
Buy
218.84%
Upside
Reiterated
11/06/25
William Blair
Buy
―
Reiterated
11/06/25
Canaccord Genuity
$10
Buy
189.86%
Upside
Reiterated
08/20/25
Goldman Sachs
$2
Sell
-42.03%
Downside
Reiterated
08/20/25
Morgan Stanley
$7
Hold
102.90%
Upside
Reiterated
08/20/25
TD Cowen
Hold
―
Reiterated
08/08/25
Jefferies
$2.5→$3
Hold
-13.04%
Downside
Reiterated
08/08/25
Analyst Type
Any
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Evercore ISI
$5
Hold
44.93%
Upside
Reiterated
12/17/25
J.P. Morgan
Sell
―
Downgraded
11/18/25
Bank of America Securities
$10→$8
Buy
131.88%
Upside
Reiterated
11/18/25
LifeSci Capital
$9
Buy
160.87%
Upside
Reiterated
11/07/25
Needham
Hold
―
Reiterated
11/07/25
Wedbush
$16
Buy
363.77%
Upside
Reiterated
11/07/25
Cantor Fitzgerald
$8
Buy
131.88%
Upside
Reiterated
11/06/25
Chardan Capital
$12→$11
Buy
218.84%
Upside
Reiterated
11/06/25
William Blair
Buy
―
Reiterated
11/06/25
Canaccord Genuity
$10
Buy
189.86%
Upside
Reiterated
08/20/25
Goldman Sachs
$2
Sell
-42.03%
Downside
Reiterated
08/20/25
Morgan Stanley
$7
Hold
102.90%
Upside
Reiterated
08/20/25
TD Cowen
Hold
―
Reiterated
08/08/25
Jefferies
$2.5→$3
Hold
-13.04%
Downside
Reiterated
08/08/25
Best Analysts Covering Rocket Pharmaceuticals
1 Month
xxx
Success Rate
16/25 ratings generated profit
Average Return
+4.76%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 64.00% of your transactions generating a profit, with an average return of +4.76% per trade.
3 Months
xxx
Success Rate
15/25 ratings generated profit
Average Return
+13.20%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 60.00% of your transactions generating a profit, with an average return of +13.20% per trade.
1 Year
Success Rate
9/16 ratings generated profit
Average Return
-2.74%
reiterated a buy rating 5 months ago
Copying Greg Harrison's trades and holding each position for 1 Year would result in 56.25% of your transactions generating a profit, with an average return of -2.74% per trade.
2 Years
xxx
Success Rate
4/15 ratings generated profit
Average Return
-54.97%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 26.67% of your transactions generating a profit, with an average return of -54.97% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
RCKT Analyst Recommendation Trends
Rating
Aug 25
Sep 25
Oct 25
Nov 25
Dec 25
Strong Buy
16
14
12
9
8
Buy
2
2
3
2
2
Hold
14
13
14
6
6
Sell
1
1
1
0
0
Strong Sell
0
0
0
1
1
total
33
30
30
18
17
Each month's total comprises the sum of three months' worth of ratings.
RCKT Financial Forecast
RCKT Stock Forecast FAQ
What is RCKT’s average 12-month price target, according to analysts?
Based on analyst ratings, Rocket Pharmaceuticals’s 12-month average price target is 9.14.
What is RCKT’s upside potential, based on the analysts’ average price target?
Rocket Pharmaceuticals has 164.93% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is RCKT a Buy, Sell or Hold?
Rocket Pharmaceuticals has a consensus rating of Moderate Buy which is based on 6 buy ratings, 3 hold ratings and 1 sell ratings.
What is Rocket Pharmaceuticals’s price target?
The average price target for Rocket Pharmaceuticals is 9.14. This is based on 10 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $16.00 ,the lowest forecast is $5.00. The average price target represents 164.93% Increase from the current price of $3.45.
The highest analyst price target is $16.00 ,the lowest forecast is $5.00. The average price target represents 164.93% Increase from the current price of $3.45.
What do analysts say about Rocket Pharmaceuticals?
Rocket Pharmaceuticals’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 10 Wall Streets Analysts.
How can I buy shares of RCKT?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.